Why is Remedium Life falling/rising?

As of 13-Aug, Remedium Lifecare Ltd's stock price is currently at 1.32, reflecting a decrease of 0.01, or 0.75%. The stock has recently underperformed its sector by 1.46% and has experienced a trend reversal, falling after two consecutive days of gains. Despite a positive performance over the past week (+5.60%) and month (+12.82%), the stock has shown significant long-term declines, with a year-to-date drop of 63.07% and a staggering 81.57% decline over the past year. The company has reported negative results for the last four consecutive quarters, with a high Debt to EBITDA ratio indicating a low ability to service debt, contributing to its poor long-term growth outlook. In the broader market context, while the Sensex has shown a slight decline of 0.01% over the past week, Remedium Lifecare's short-term performance has been significantly better, suggesting some investor interest despite the overall negative sentiment. However, the stock's long-term performance has been severely lacking compared to the benchmark, which has generated a positive return of 2.01% over the past year. The company's ongoing financial struggles, including a fall in net sales and negative operating profit growth, continue to weigh heavily on investor confidence, leading to the current downward pressure on the stock price.